Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Ajai Chari, Hartmut Goldschmidt, Jesus San-Miguel, Helen McCarthy, Kenshi Suzuki, VANIA HUNGRIA, Anna Sureda Balari, Aurore Perrot, Cyrille HULIN, Hila Magen, Shinsuke Iida, Vladimir Maisnar, Lionel KARLIN, Ludek Pour, Dolly Parasrampuria, Tara Masterson, Michele Kosh, shiyi yang, Ming Qi, Robin Carson, Philippe Moreau | ||||||||||||
Title | Subcutaneous (SC) Daratumumab (DARA) in Combination With Standard Multiple Myeloma (MM) Treatment Regimens: An Open-label, Multicenter Phase 2 Study (PLEIADES) | ||||||||||||
|
|||||||||||||
URL | http://imw2019boston.org/images/Abstracts/17th_IMW_Abstract_Book_FINAL_V2.pdf | ||||||||||||
Abstract Text | 17th International Myeloma Workshop Sep 2019, Boston, MA, US. OAB-022 |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|